Condition: Tachycardia Atrial · Atrial Fibrillation · Atrial Flutter With Rapid Ventricular Response · Sponsor: Wake Forest University Health Sciences
The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.
This description comes directly from the study's public registry record.
Marc McDowell, PharmD · (708) 684-1078 · marc.mcdowell@aah.org
Always discuss trial participation with your own doctor first.
| Advocate Christ Medical Center Emergency Department (ACMC ED) | Oak Lawn, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06376916